Home
About
FAQ
History (11)
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines.
Prevention of obesity-induced breast cancer and tamoxifen drug resistance.
Response.
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19.
Uses of Procalcitonin as a Biomarker in Critical Care Medicine.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Uses of Procalcitonin as a Biomarker in Critical Care Medicine.
Maves RC, Enwezor CH. Uses of Procalcitonin as a Biomarker in Critical Care Medicine. Infect Dis Clin North Am. 2022 Dec; 36(4):897-909.
View in:
PubMed
subject areas
Anti-Bacterial Agents
Bacterial Infections
Critical Care
Critical Illness
Humans
Sepsis
Virus Diseases
authors with profiles
Ryan C. Maves MD